Fundz
New|Fundz now works inside Claude2 min

AI made execution free. Knowing first is the whole game now.

The advantage goes to whoever is first into the right conversations, most often. Fundz stacks those odds: more of the moments that create demand than anyone else catches, as they happen, matched to who you sell to, with the decision maker to call. Now it answers in Claude too: ask for today’s leads and who to reach, then write the note in the same window. Not a feed. Not a list you rent. A system for being first.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

UltraSight raises $24 million in Series B2 financing to expand its AI-guided cardiac workflow platform across U.S. health systems, led by Alive HealthTech Growth Fund.

PRIVATESep 23, 2026•about 4 hours ago

Amount Raised

$24 Million

Round Type

Venture - Series Unknown

BostonBiotechnologyHealth CareArtificial IntelligenceMedicalMedical DeviceMachine LearningHealth Diagnostics

Investors

Iron NationNyuMayo Clinic VenturesE Health VenturesConnecticut InnovationsStar51 CapitalDeep InsightAlive Health Tech Growth Fund

Description

UltraSight has successfully raised $24 million in Series B2 funding to support the commercial expansion of its Echosystem platform in the United States. This financing aims to develop high-value workflows for critical care settings and facilitate strategic collaborations. The funding was led by Alive HealthTech Growth Fund with participation from several other investors, including existing partners. This capital will help UltraSight enhance its market presence and improve cardiac imaging workflows.

Company Information

Company

UltraSight

Location

Boston, Massachusetts, United States

About

UltraSight is a leader in AI-guided cardiac workflows, focused on enhancing cardiac care through its Echosystem platform. The company aims to facilitate real-time imaging decisions that significantly impact patient management in critical care and cardiovascular settings. UltraSight combines proprietary AI innovations with clinical evidence to support broader cardiac imaging workflows. It is committed to improving access to high-quality cardiac ultrasound for better patient outcomes.

Fundz sees it the moment UltraSight raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for UltraSight's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

UltraSight raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 285,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.